Tech Company Financing Transactions
Magenta Medical Funding Round
On 7/23/2024, Magenta Medical raised $105 million in financing from Novo Holdings, ALIVE Israel HealthTech Fund and JVC Investment Partners.
Transaction Overview
Company Name
Announced On
7/23/2024
Transaction Type
Venture Equity
Amount
$105,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance its U.S. clinical programs in multiple mechanical circulatory support (MCS) indications and to secure the first FDA approval for the Elevate� System in patients undergoing high-risk percutaneous coronary interventions (HR-PCI).
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
10 Allen St.
Hanover, NH 03755
USA
Hanover, NH 03755
USA
Phone
Email Address
Not Recorded
Overview
Magenta Medical is developing a device that provides hemostasis during minimally-invasive off pump coronary artery bypass graft surgery, without the use of an aortic clamp.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ehud Schwammenthal
Browse more venture capital transactions:
Prev: 7/23/2024: Multipool venture capital transaction
Next: 7/23/2024: AppMagic venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs